Race Oncology Ltd (RAC) — Strategic Asset Allocation Index
Race Oncology Ltd (RAC) has a Strategic Asset Allocation Index of 0.0% as of December 2023. Strategic assets (PP&E of AU$3.27K plus long-term investments of AU$-) total AU$3.27K, measured against net assets of AU$20.43 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Race Oncology Ltd Strategic Asset Allocation Index (2011–2013)
This chart shows how Race Oncology Ltd's Strategic Asset Allocation Index has evolved across 4 annual periods from 2011 to 2013. As of December 2023, the index stands at 0.0%, representing strategic assets of AU$3.27K against net assets of AU$20.43 Million AUD. Explore RAC operating cash flow to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Race Oncology Ltd (2011–2013)
The table below presents the year-by-year Strategic Asset Allocation Index for Race Oncology Ltd from 2011 to 2013, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Race Oncology Ltd (RAC) total market value.
| Year | SAAI | Strategic Assets (AUD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2013 | 58.9% | AU$58.27 Million | AU$1.82 Million | AU$56.45 Million | AU$98.97 Million | ▼ -6.6 pp |
| 2012 | 65.5% | AU$62.78 Million | AU$2.18 Million | AU$60.60 Million | AU$95.85 Million | ▲ +41.3 pp |
| 2012 | 24.2% | AU$22.86 Million | AU$2.48 Million | AU$20.38 Million | AU$94.45 Million | ▼ -50.5 pp |
| 2011 | 74.7% | AU$80.00 Million | AU$2.85 Million | AU$77.15 Million | AU$107.05 Million | — |